156 related articles for article (PubMed ID: 8745977)
21. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
[TBL] [Abstract][Full Text] [Related]
24. Effect of renal function on neuromuscular block induced by continuous infusion of mivacurium.
Blobner M; Jelen-Esselborn S; Schneider G; Mann R; Kling M; Luppa P; Schneck HJ; Kochs E
Br J Anaesth; 1995 Apr; 74(4):452-4. PubMed ID: 7734267
[TBL] [Abstract][Full Text] [Related]
25. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
Cerf C; Mesguish M; Gabriel I; Amselem S; Duvaldestin P
Anesth Analg; 2002 Feb; 94(2):461-6, table of contents. PubMed ID: 11812719
[TBL] [Abstract][Full Text] [Related]
26. Effect of metoclopramide on mivacurium-induced neuromuscular block.
Motamed C; Kirov K; Combes X; Dhonneur G; Duvaldestin P
Acta Anaesthesiol Scand; 2002 Feb; 46(2):214-6. PubMed ID: 11942874
[TBL] [Abstract][Full Text] [Related]
27. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
Frampton JE; McTavish D
Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
[TBL] [Abstract][Full Text] [Related]
28. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
[TBL] [Abstract][Full Text] [Related]
29. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
[TBL] [Abstract][Full Text] [Related]
30. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
[TBL] [Abstract][Full Text] [Related]
31. [Prolonged neuromuscular blockade caused by mivacurium].
Péchinot M; Galloux Y
Ann Fr Anesth Reanim; 1996; 15(5):693-4. PubMed ID: 9033774
[No Abstract] [Full Text] [Related]
32. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
[TBL] [Abstract][Full Text] [Related]
33. [Prolonged curarization with mivacurium and suxamethonium: will molecular biology allow a diagnostic and therapeutic approach?].
Duvaldestin P
Ann Fr Anesth Reanim; 1995; 14(6):465-6. PubMed ID: 8745968
[No Abstract] [Full Text] [Related]
34. Neuromuscular and hemodynamic effects of mivacurium and succinylcholine in adult patients during nitrous oxide-propofol-fentanyl anesthesia.
Hwang KH; Kim SC; Kim SY; Ueda N; Muteki T
J Korean Med Sci; 1993 Oct; 8(5):374-9. PubMed ID: 8305145
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamics of mivacurium in severely burned patients.
Werba AE; Neiger FX; Bayer GS; Schultz AM; Maitz PK; Wolrab C
Burns; 1996 Feb; 22(1):62-4. PubMed ID: 8719320
[TBL] [Abstract][Full Text] [Related]
36. Postpartum patients have slightly prolonged neuromuscular block after mivacurium.
Gin T; Derrick JL; Chan MT; Chui PT; Mak TW
Anesth Analg; 1998 Jan; 86(1):82-5. PubMed ID: 9428856
[TBL] [Abstract][Full Text] [Related]
37. [Prolonged curarization after administration of mivacurium].
Soulard D; Blanloeil Y; de Laroche O; Burnat P; Magerand P
Cah Anesthesiol; 1996; 44(5):429-31. PubMed ID: 9183424
[No Abstract] [Full Text] [Related]
38. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium.
Lessard MR; Trépanier CA; Rouillard JF
Can J Anaesth; 1997 Aug; 44(8):836-42. PubMed ID: 9260011
[TBL] [Abstract][Full Text] [Related]
39. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
[TBL] [Abstract][Full Text] [Related]
40. [Mivacurium in pediatric anesthesia].
Hofmockel VR; Pohl B; Benad G
Anaesthesiol Reanim; 1996; 21(1):11-3. PubMed ID: 8901179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
